Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
33 /100
MEDIUM RISK
Score updated Oct 13, 2026

BPTH — Bio-Path Holdings, Inc. Dilution Risk Tracker

Track BPTH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BPTH — Get alerts when the score changes →

As of October 13, 2026, Bio-Path Holdings, Inc. (BPTH) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. Bio-Path Holdings, Inc. has a market capitalization of $10.1K, 50.30M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 190.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.05 below $1 exchange minimum
🔔 Track BPTH — Get forecast alerts →

Market Data

Market Cap$10.1K
Shares Outstanding50.30M
Float49.91M
CashN/A
Debt$511.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore33/100DilutionWatch score record
Shares Outstanding50.30MVerified float table or market cache
Public Float49.91MVerified float table or market cache
Market Cap$10.1KMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants190.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 8-K 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

1 institutional holders · 4 shares
#1 DANSKE BANK A/S 4 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.4K
Days to Cover1.0
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-01-13
xbrl XBRL WARRANT 2025-03-27
8-K 8K EVENT 2026-03-20
8-K 8K EVENT 2026-02-24
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BPTH Dilution Snapshot

Bio-Path Holdings, Inc. (BPTH) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BPTH's DilutionScore is currently 33/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 36/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202633/100MEDIUM53 days
Aug 14 – Aug 21, 202636/100MEDIUM7 days
Jul 16 – Aug 13, 202633/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track BPTH Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BPTH files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BPTH — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BPTH
BPTH FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.